+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Diabetes Devices Market Size, Share & Trends Analysis Report by Type (Blood Glucose Monitoring Devices, Insulin Delivery Devices), Distribution Channel (Hospital Pharmacies, Retail Pharmacies), End-use, Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 195 Pages
  • March 2024
  • Region: Global
  • Grand View Research
  • ID: 4599560
Description Jump to:
The global diabetes devices market size is expected to reach USD 50.33 billion by 2030, registering a CAGR of 7.45% from 2024 to 2030. The market is primarily driven by factors such as the increasing incidence of diabetes, coupled with technological advancements and innovative product launches.

Rising adoption of advanced diabetes management solutions in developing regions, government policies, and rising medical tourism are some of the major factors contributing to the market growth. Furthermore, the rising government initiative to spread diabetes awareness and increasing R&D expenditure of major market players are the factors expected to ensure long-term market growth. According to the NCBI report, global health expenditure on diabetes is expected to reach USD 490 billion in 2030 from 376 billion in 2010.

Obesity, sedentary lifestyle, and fast food culture are some of the factors having a significant impact on the market growth. According to Harvard T.H. Chan School of Public Health, the U.S has the highest rates of obesity with every third person being obese and this rate is expected to reach 50% by 2030.

In addition, an increasing number of new market players are transforming the market. New market entrants focus on patient convenience with the help of artificial intelligence technology. They are leveraging technological advancements to improve diabetes care solutions like CGM devices non-invasive insulin delivery systems and digital diabetes management platforms. For Instance, In December 2017, Companion Medical Launched Inpen, its first smart insulin pen system in the U.S. It is the only FDA-approved solution that can combine insulin injector pens with a smart app.

Diabetes Devices Market Report Highlights

  • North America accounted for the largest share of 38.66% in 2023 owing to favorable reimbursement policies, the presence of key players, and frequent product launches
  • By type, the insulin delivery devices market accounted for the largest market size and is also expected to grow at the fastest rate
  • By BGM devices, self-monitoring devices are dominating the market owing to their low cost and high usage
  • By SMBG devices, testing strips is dominating the market while blood glucose meter is growing at a rapid pace owing to the high adoption of these devices and technological advancement
  • By CGM device, the transmitter segment accounted for the largest market share owing to the high cost of devices
  • By insulin delivery devices, the pens segment is dominating the market owing to its low cost as compared to other delivery devices and it is also easy to carry and use
  • By distribution channels, the hospital pharmacy segment dominated the market 54.3% owing to the rise in sales of diabetes devices in these pharmacies
  • By end-use, the Hospital segment accounted for the largest market share of 40.9% owing to improving healthcare infrastructure due to rising investment
  • Market leaders are focusing on product launches and technological collaboration.

Table of Contents

Chapter 1. Diabetes Devices Market: Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Distribution Channel
1.2.3. End-use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. Internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Diabetes Devices Market: Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Distribution Channel outlook
2.2.3. End Use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Diabetes Devices Market: Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Growing prevalence of obesity and diabetes
3.2.1.2. Technological Innovations & Product Advancements
3.2.1.3. Growing focus on diabetes care
3.2.1.4. Untapped opportunities in developing economies
3.2.2. Market restraint analysis
3.2.2.1. Stringent regulatory policies and regulations
3.2.2.2. High cost of devices
3.3. Diabetes Devices Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
Chapter 4. Diabetes Devices Market: Type Estimates & Trend Analysis
4.1. Type Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Diabetes Devices Market, by Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5. Blood Glucose Monitoring Devices
4.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.2. Self-Monitoring Devices
4.5.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.2.2. Blood Glucose Meters
4.5.2.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.2.3. Testing Strips
4.5.2.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.2.4. Lancets
4.5.2.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.3. Continuous Glucose-Monitoring Devices
4.5.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.3.2. Sensors
4.5.3.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.3.3. Transmitters
4.5.3.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.3.4. Receiver
4.5.3.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Insulin Delivery Devices
4.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.6.2. Insulin Pumps
4.6.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.6.3. Insulin Pens
4.6.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.6.4. Insulin Syringes
4.6.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.6.5. Insulin Jet injectors
4.6.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Diabetes Devices Market: Distribution Channel Estimates & Trend Analysis
5.1. Distribution Channel Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Diabetes Devices Market, by Distribution Channel Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Hospital Pharmacies
5.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Retail Pharmacies
5.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Diabetes Clinics/Centers
5.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.8. Online Pharmacies
5.8.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.9. Others
5.9.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Diabetes Devices Market: End Use Estimates & Trend Analysis
6.1. End Use Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Global Diabetes Devices Market, by End Use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5. Hospitals
6.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Diagnostic Centers
6.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.7. Homecare
6.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Diabetes Devices Market: Regional Estimates & Trend Analysis by Country, Type, Distribution Channel, and End Use
7.1. Regional Market Dashboard
7.2. Global Regional Market Snapshot
7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.4. North America
7.4.1. U.S.
7.4.1.1. Key country dynamics
7.4.1.2. Regulatory framework
7.4.1.3. Reimbursement structure
7.4.1.4. Competitive scenario
7.4.1.5. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.2. Canada
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework
7.4.2.3. Reimbursement structure
7.4.2.4. Competitive scenario
7.4.2.5. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
7.5. Europe
7.5.1. UK
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework
7.5.1.3. Reimbursement structure
7.5.1.4. Competitive scenario
7.5.1.5. UK market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.2. Germany
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework
7.5.2.3. Reimbursement structure
7.5.2.4. Competitive scenario
7.5.2.5. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.3. France
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework
7.5.3.3. Reimbursement structure
7.5.3.4. Competitive scenario
7.5.3.5. France market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.4. Italy
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework
7.5.4.3. Reimbursement structure
7.5.4.4. Competitive scenario
7.5.4.5. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.5. Spain
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework
7.5.5.3. Reimbursement structure
7.5.5.4. Competitive scenario
7.5.5.5. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.6. Norway
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework
7.5.6.3. Reimbursement structure
7.5.6.4. Competitive scenario
7.5.6.5. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.7. Sweden
7.5.7.1. Key country dynamics
7.5.7.2. Regulatory framework
7.5.7.3. Reimbursement structure
7.5.7.4. Competitive scenario
7.5.7.5. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.8. Denmark
7.5.8.1. Key country dynamics
7.5.8.2. Regulatory framework
7.5.8.3. Reimbursement structure
7.5.8.4. Competitive scenario
7.5.8.5. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
7.6. Asia Pacific
7.6.1. Japan
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework
7.6.1.3. Reimbursement structure
7.6.1.4. Competitive scenario
7.6.1.5. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.2. China
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework
7.6.2.3. Reimbursement structure
7.6.2.4. Competitive scenario
7.6.2.5. China market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.3. India
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework
7.6.3.3. Reimbursement structure
7.6.3.4. Competitive scenario
7.6.3.5. India market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.4. Australia
7.6.4.1. Key country dynamics
7.6.4.2. Regulatory framework
7.6.4.3. Reimbursement structure
7.6.4.4. Competitive scenario
7.6.4.5. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.5. South Korea
7.6.5.1. Key country dynamics
7.6.5.2. Regulatory framework
7.6.5.3. Reimbursement structure
7.6.5.4. Competitive scenario
7.6.5.5. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.6. Thailand
7.6.6.1. Key country dynamics
7.6.6.2. Regulatory framework
7.6.6.3. Reimbursement structure
7.6.6.4. Competitive scenario
7.6.6.5. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
7.7. Latin America
7.7.1. Brazil
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework
7.7.1.3. Reimbursement structure
7.7.1.4. Competitive scenario
7.7.1.5. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.2. Mexico
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework
7.7.2.3. Reimbursement structure
7.7.2.4. Competitive scenario
7.7.2.5. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.3. Argentina
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework
7.7.3.3. Reimbursement structure
7.7.3.4. Competitive scenario
7.7.3.5. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
7.8. MEA
7.8.1. South Africa
7.8.1.1. Key country dynamics
7.8.1.2. Regulatory framework
7.8.1.3. Reimbursement structure
7.8.1.4. Competitive scenario
7.8.1.5. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
7.8.2. Saudi Arabia
7.8.2.1. Key country dynamics
7.8.2.2. Regulatory framework
7.8.2.3. Reimbursement structure
7.8.2.4. Competitive scenario
7.8.2.5. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
7.8.3. UAE
7.8.3.1. Key country dynamics
7.8.3.2. Regulatory framework
7.8.3.3. Reimbursement structure
7.8.3.4. Competitive scenario
7.8.3.5. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
7.8.4. Kuwait
7.8.4.1. Key country dynamics
7.8.4.2. Regulatory framework
7.8.4.3. Reimbursement structure
7.8.4.4. Competitive scenario
7.8.4.5. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Key Company Market Share Analysis, 2023
8.4. Company Position Analysis, 2023
8.5. Company Categorization (Emerging Players, Innovators, and Leaders)
8.6. Company Profiles
8.6.1. Medtronic plc
8.6.1.1. Company overview
8.6.1.2. Financial performance
8.6.1.3. Product benchmarking
8.6.1.4. Strategic initiatives
8.6.2. Abbott Laboratories
8.6.2.1. Company overview
8.6.2.2. Financial performance
8.6.2.3. Product benchmarking
8.6.2.4. Strategic initiatives
8.6.3. Ascensia Diabetes Care Holdings
8.6.3.1. Company overview
8.6.3.2. Financial performance
8.6.3.3. Product benchmarking
8.6.3.4. Strategic initiatives
8.6.4. AG F.Hoffmann-La-Ltd
8.6.4.1. Company overview
8.6.4.2. Financial performance
8.6.4.3. Product benchmarking
8.6.4.4. Strategic initiatives
8.6.5. Dexcom, Inc.
8.6.5.1. Company overview
8.6.5.2. Financial performance
8.6.5.3. Product benchmarking
8.6.5.4. Strategic initiatives
8.6.6. Bayer AG
8.6.6.1. Company overview
8.6.6.2. Financial performance
8.6.6.3. Product benchmarking
8.6.6.4. Strategic initiatives
8.6.7. Hoffmann-La Roche Ltd.
8.6.7.1. Company overview
8.6.7.2. Financial performance
8.6.7.3. Product benchmarking
8.6.7.4. Strategic initiatives
8.6.8. B Braun Melsungen AG
8.6.8.1. Company overview
8.6.8.2. Financial performance
8.6.8.3. Product benchmarking
8.6.8.4. Strategic initiatives
8.6.9. Lifescan, Inc.
8.6.9.1. Company overview
8.6.9.2. Financial performance
8.6.9.3. Product benchmarking
8.6.9.4. Strategic initiatives
8.6.10. Dexcom Inc.
8.6.10.1. Company overview
8.6.10.2. Financial performance
8.6.10.3. Product benchmarking
8.6.10.4. Strategic initiatives
8.6.11. Insulet Corporation
8.6.11.1. Company overview
8.6.11.2. Financial performance
8.6.11.3. Product benchmarking
8.6.11.4. Strategic initiatives
8.6.12. Ypsomed Holdings
8.6.12.1. Company overview
8.6.12.2. Financial performance
8.6.12.3. Product benchmarking
8.6.12.4. Strategic initiatives
8.6.13. Companion Medical
8.6.13.1. Company overview
8.6.13.2. Financial performance
8.6.13.3. Product benchmarking
8.6.13.4. Strategic initiatives
8.6.14. Sanofi
8.6.14.1. Company overview
8.6.14.2. Financial performance
8.6.14.3. Product benchmarking
8.6.14.4. Strategic initiatives
8.6.15. Valeritas Holding Inc.
8.6.15.1. Company overview
8.6.15.2. Financial performance
8.6.15.3. Product benchmarking
8.6.15.4. Strategic initiatives
8.6.16. Novo Nordisk
8.6.16.1. Company overview
8.6.16.2. Financial performance
8.6.16.3. Product benchmarking
8.6.16.4. Strategic initiatives
8.6.17. Arkray, Inc.
8.6.17.1. Company overview
8.6.17.2. Financial performance
8.6.17.3. Product benchmarking
8.6.17.4. Strategic initiatives
List of Tables
Table 1. List of secondary sources
Table 2. List of abbreviation
Table 3. North America diabetes devices market, by country, 2018 - 2030 (USD Million)
Table 4. North America diabetes devices market, by type, 2018 - 2030 (USD Million)
Table 5. North America diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 6. North America diabetes devices market, by end use, 2018 - 2030 (USD Million)
Table 7. U.S. diabetes devices market, by type, 2018 - 2030 (USD Million)
Table 8. U.S. diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 9. U.S. diabetes devices market, by end use, 2018 - 2030 (USD Million)
Table 10. Canada diabetes devices market, by type, 2018 - 2030 (USD Million)
Table 11. Canada diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 12. Canada diabetes devices market, by end use, 2018 - 2030 (USD Million)
Table 13. Europe diabetes devices market, by country, 2018 - 2030 (USD Million)
Table 14. Europe diabetes devices market, by type, 2018 - 2030 (USD Million)
Table 15. Europe diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 16. Europe diabetes devices market, by end use, 2018 - 2030 (USD Million)
Table 17. UK diabetes devices market, by type, 2018 - 2030 (USD Million)
Table 18. UK diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 19. UK diabetes devices market, by end use, 2018 - 2030 (USD Million)
Table 20. Germany diabetes devices market, by type, 2018 - 2030 (USD Million)
Table 21. Germany diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 22. Germany diabetes devices market, by end use, 2018 - 2030 (USD Million)
Table 23. France diabetes devices market, by type, 2018 - 2030 (USD Million)
Table 24. France diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 25. France diabetes devices market, by end use, 2018 - 2030 (USD Million)
Table 26. Italy diabetes devices market, by type, 2018 - 2030 (USD Million)
Table 27. Italy diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 28. Italy diabetes devices market, by end use, 2018 - 2030 (USD Million)
Table 29. Denmark diabetes devices market, by type, 2018 - 2030 (USD Million)
Table 30. Denmark diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 31. Denmark diabetes devices market, by end use, 2018 - 2030 (USD Million)
Table 32. Sweden diabetes devices market, by type, 2018 - 2030 (USD Million)
Table 33. Sweden diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 34. Sweden diabetes devices market, by end use, 2018 - 2030 (USD Million)
Table 35. Norway diabetes devices market, by type, 2018 - 2030 (USD Million)
Table 36. Norway diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 37. Norway diabetes devices market, by end use, 2018 - 2030 (USD Million)
Table 38. Asia Pacific diabetes devices market, by country, 2018 - 2030 (USD Million)
Table 39. Asia Pacific diabetes devices market, by type, 2018 - 2030 (USD Million)
Table 40. Asia Pacific diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 41. Asia Pacific diabetes devices market, by end use, 2018 - 2030 (USD Million)
Table 42. Japan diabetes devices market, by type, 2018 - 2030 (USD Million)
Table 43. Japan diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 44. Japan diabetes devices market, by end use, 2018 - 2030 (USD Million)
Table 45. China diabetes devices market, by type, 2018 - 2030 (USD Million)
Table 46. China diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 47. China diabetes devices market, by end use, 2018 - 2030 (USD Million)
Table 48. India diabetes devices market, by type, 2018 - 2030 (USD Million)
Table 49. India diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 50. India diabetes devices market, by end use, 2018 - 2030 (USD Million)
Table 51. Australia diabetes devices market, by type, 2018 - 2030 (USD Million)
Table 52. Australia diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 53. Australia diabetes devices market, by end use, 2018 - 2030 (USD Million)
Table 54. South Korea diabetes devices market, by type, 2018 - 2030 (USD Million)
Table 55. South Korea diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 56. South Korea diabetes devices market, by end use, 2018 - 2030 (USD Million)
Table 57. Thailand diabetes devices market, by type, 2018 - 2030 (USD Million)
Table 58. Thailand diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 59. Thailand diabetes devices market, by end use, 2018 - 2030 (USD Million)
Table 60. Latin America diabetes devices market, by Country, 2018 - 2030 (USD Million)
Table 61. Latin America diabetes devices market, by type, 2018 - 2030 (USD Million)
Table 62. Latin America diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 63. Latin America diabetes devices market, by end use, 2018 - 2030 (USD Million)
Table 64. Brazil diabetes devices market, by type, 2018 - 2030 (USD Million)
Table 65. Brazil diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 66. Brazil diabetes devices market, by end use, 2018 - 2030 (USD Million)
Table 67. Mexico diabetes devices market, by type, 2018 - 2030 (USD Million)
Table 68. Mexico diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 69. Mexico diabetes devices market, by end use, 2018 - 2030 (USD Million)
Table 70. Argentina diabetes devices market, by type, 2018 - 2030 (USD Million)
Table 71. Argentina diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 72. Argentina diabetes devices market, by end use, 2018 - 2030 (USD Million)
Table 73. Middle East & Africa diabetes devices market, by country, 2018 - 2030 (USD Million)
Table 74. Middle East & Africa diabetes devices market, by type, 2018 - 2030 (USD Million)
Table 75. Middle East & Africa diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 76. Middle East & Africa diabetes devices market, by end use, 2018 - 2030 (USD Million)
Table 77. South Africa diabetes devices market, by type, 2018 - 2030 (USD Million)
Table 78. South Africa diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 79. South Africa diabetes devices market, by end use, 2018 - 2030 (USD Million)
Table 80. Saudi Arabia diabetes devices market, by type, 2018 - 2030 (USD Million)
Table 81. Saudi Arabia diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 82. Saudi Arabia diabetes devices market, by end use, 2018 - 2030 (USD Million)
Table 83. UAE diabetes devices market, by type, 2018 - 2030 (USD Million)
Table 84. UAE diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 85. UAE diabetes devices market, by end use, 2018 - 2030 (USD Million)
Table 86. Kuwait diabetes devices market, by type, 2018 - 2030 (USD Million)
Table 87. Kuwait diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 88. Kuwait diabetes devices market, by end use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Diabetes devices market: Market outlook
Fig. 14 Diabetes devices market competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Diabetes devices market driver impact
Fig. 20 Diabetes devices market restraint impact
Fig. 21 Diabetes devices market: type movement analysis
Fig. 22 Diabetes devices market: type outlook and key takeaways
Fig. 23 Blood glucose monitoring devices market estimates and forecast, 2018 - 2030
Fig. 24 Self-monitoring devices market estimates and forecast, 2018 - 2030
Fig. 25 Blood glucose meters market estimates and forecast, 2018 - 2030
Fig. 26 Testing strips market estimates and forecast, 2018 - 2030
Fig. 27 Lancets market estimates and forecast, 2018 - 2030
Fig. 28 Continuous glucose monitoring devices market estimates and forecast, 2018 - 2030
Fig. 29 Sensors market estimates and forecast, 2018 - 2030
Fig. 30 Transmitters market estimates and forecast, 2018 - 2030
Fig. 31 Receivers market estimates and forecast, 2018 - 2030
Fig. 32 Insulin delivery devices market estimates and forecast, 2018 - 2030
Fig. 33 Insulin pumps market estimates and forecast, 2018 - 2030
Fig. 34 Insulin pens market estimates and forecast, 2018 - 2030
Fig. 35 Insulin syringes market estimates and forecast, 2018 - 2030
Fig. 36 Insulin jet injectors market estimates and forecast, 2018 - 2030
Fig. 37 Diabetes devices market: distribution channel movement analysis
Fig. 38 Diabetes devices market: distribution channel outlook and key takeaways
Fig. 39 Hospital pharmacies market estimates and forecast, 2018 - 2030
Fig. 40 Retail pharmacies market estimates and forecast, 2018 - 2030
Fig. 41 Diabetes clinics/centers market estimates and forecast, 2018 - 2030
Fig. 42 Online pharmacies market estimates and forecast, 2018 - 2030
Fig. 43 Others market estimates and forecast, 2018 - 2030
Fig. 44 Diabetes devices market: end use movement analysis
Fig. 45 Diabetes devices market: end use outlook and key takeaways
Fig. 46 Hospitals market estimates and forecast, 2018 - 2030
Fig. 47 Diagnostic centers market estimates and forecast, 2018 - 2030
Fig. 48 Homecare market estimates and forecast, 2018 - 2030
Fig. 49 Global Diabetes devices market: regional movement analysis
Fig. 50 Global Diabetes devices market: regional outlook and key takeaways
Fig. 51 North America
Fig. 52 North America market estimates and forecast, 2018 - 2030
Fig. 53 U.S.
Fig. 54 U.S. market estimates and forecast, 2018 - 2030
Fig. 55 Canada
Fig. 56 Canada market estimates and forecast, 2018 - 2030
Fig. 57 Europe
Fig. 58 Europe. market estimates and forecast, 2018 - 2030
Fig. 59 UK
Fig. 60 UK market estimates and forecast, 2018 - 2030
Fig. 61 Germany
Fig. 62 Germany market estimates and forecast, 2018 - 2030
Fig. 63 France
Fig. 64 France market estimates and forecast, 2018 - 2030
Fig. 65 Italy
Fig. 66 Italy market estimates and forecast, 2018 - 2030
Fig. 67 Spain
Fig. 68 Spain market estimates and forecast, 2018 - 2030
Fig. 69 Denmark
Fig. 70 Denmark market estimates and forecast, 2018 - 2030
Fig. 71 Sweden
Fig. 72 Sweden market estimates and forecast, 2018 - 2030
Fig. 73 Norway
Fig. 74 Norway market estimates and forecast, 2018 - 2030
Fig. 75 Asia Pacific
Fig. 76 Asia Pacific market estimates and forecast, 2018 - 2030
Fig. 77 Japan
Fig. 78 Japan market estimates and forecast, 2018 - 2030
Fig. 79 China
Fig. 80 China market estimates and forecast, 2018 - 2030
Fig. 81 India
Fig. 82 India market estimates and forecast, 2018 - 2030
Fig. 83 South Korea
Fig. 84 South Korea market estimates and forecast, 2018 - 2030
Fig. 85 Thailand
Fig. 86 Thailand market estimates and forecast, 2018 - 2030
Fig. 87 Australia
Fig. 88 Australia market estimates and forecast, 2018 - 2030
Fig. 89 Latin America
Fig. 90 Latin America market estimates and forecast, 2018 - 2030
Fig. 91 Brazil
Fig. 92 Brazil market estimates and forecast, 2018 - 2030
Fig. 93 Mexico
Fig. 94 Mexico market estimates and forecast, 2018 - 2030
Fig. 95 Argentina
Fig. 96 Argentina market estimates and forecast, 2018 - 2030
Fig. 97 Middle East and Africa
Fig. 98 Middle East and Africa. market estimates and forecast, 2018 - 2030
Fig. 99 Saudi Arabia
Fig. 100 Saudi Arabia market estimates and forecast, 2018 - 2030
Fig. 101 South Africa
Fig. 102 South Africa market estimates and forecast, 2018 - 2030
Fig. 103 UAE
Fig. 104 UAE market estimates and forecast, 2018 - 2030
Fig. 105 Kuwait
Fig. 106 Kuwait market estimates and forecast, 2018 - 2030
Fig. 107 Participant categorization- Diabetes devices market
Fig. 108 Market share of key market players- Diabetes devices market

Companies Mentioned

  • Medtronic plc
  • Abbott Laboratories
  • Ascensia Diabetes Care Holdings
  • AG F.Hoffmann-La-Ltd
  • Dexcom, Inc.
  • Bayer AG
  • Hoffmann-La Roche Ltd.
  • B Braun Melsungen AG
  • Lifescan, Inc.
  • Dexcom Inc.
  • Insulet Corporation
  • Ypsomed Holdings
  • Companion Medical
  • Sanofi
  • Valeritas Holding Inc.
  • Novo Nordisk
  • Arkray, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages195
PublishedMarch 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 30.31 Billion
Forecasted Market Value ( USD ) by 2030 $ 50.33 Billion
Compound Annual Growth Rate7.4%
Regions CoveredGlobal
No. of Companies Mentioned17

Related Topics

Related Reports

United States Diabetes Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029 - Product Image

United States Diabetes Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029

  • Report
  • 70 Pages
  • United States
From
Diabetes Devices and Drugs Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030 - Product Image

Diabetes Devices and Drugs Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030

  • Report
  • 180 Pages
  • Global
From
Insulin Delivery Devices Market Size, Share & Trends Analysis Report By Product (Reusable Insulin Pens, Disposable Insulin Pens), By End Use (Hospitals & Clinics, Homecare), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Insulin Delivery Devices Market Size, Share & Trends Analysis Report By Product (Reusable Insulin Pens, Disposable Insulin Pens), By End Use (Hospitals & Clinics, Homecare), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 150 Pages
  • Global
From
Continuous Glucose Monitoring Devices Market Size, Share, & Trends Analysis Report by Component (Transmitters, Sensors, Receivers), End-use (Hospitals, Homecare), Connectivity, Region and Segment Forecasts, 2024-2030 - Product Image

Continuous Glucose Monitoring Devices Market Size, Share, & Trends Analysis Report by Component (Transmitters, Sensors, Receivers), End-use (Hospitals, Homecare), Connectivity, Region and Segment Forecasts, 2024-2030

  • Report
  • 175 Pages
  • Global
From
Glucose Monitoring Devices Market by Type, Application, End-User - Global Forecast 2025-2030 - Product Image

Glucose Monitoring Devices Market by Type, Application, End-User - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From

About the Diabetes Devices Market

The Diabetes Devices market is a sector of the healthcare industry that focuses on the development and production of medical devices used to monitor and treat diabetes. These devices include glucose meters, insulin pumps, continuous glucose monitoring systems, and other related products. Glucose meters are used to measure the amount of glucose in the blood, while insulin pumps are used to deliver insulin to the body. Continuous glucose monitoring systems are used to track glucose levels over time. Other products include lancets, test strips, and other accessories. The Diabetes Devices market is highly competitive, with many companies offering a wide range of products. Some of the leading companies in the market include Abbott, Medtronic, Dexcom, Insulet, and Roche. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.